We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byIrea Boyle
Modified over 3 years ago
MSS 01DEC06 1 Compliance Activities 2006 New England District Office FDA CAPT Mutahar Shamsi, USPHS Director, Compliance Branch
MSS 01DEC062 Top 5 Device 483 Cites Top 5 Device 483 Cites CFR (a), maintain Complaint files 2. 21CFR (a), establish Corrective & preventive action procedures CFR , written MDR procedures 4. 21CFR820.75(a), Process validation 5. 21CFR (b), document Corrective & preventive action 5. 21CFR820.22, Quality audit procedures; Management w/ executive responsibility(2005)
MSS 01DEC Top 5 NWE-DO Device 483 Cites 1. 21CFR820.22, Quality audit 2. 21CFR820.25(b), Training documentation 3. 21CFR (a), maintain Complaint files 4. 21CFR (b), document Corrective & preventive action 5. 21CFR (a), establish Corrective & preventive action
MSS 01DEC Top 5 NWE-DO Device 483 Cites 1. 21CFR (b), document Corrective & preventive action 2. 21CFR (a), maintain Complaint files 3. 21CFR820.22, Quality audit 4. 21CFR (a) establish Corrective & preventive action
MSS 01DEC Top 5 NWE-DO Device 483 Cites 5. 21CFR820.25(b) establish Training procedures; 21CFR803.50(a)(2), MDRs malfunctions; 21CFR (b), document Corrective & preventive action; 21CFR (a)(3), MDR evaluation
MSS 01DEC NWE-DO Device Cites by Section 1. Corrective & preventive action 2. Quality audit 3. Complaint files 4. Medical Device Reporting 5. Personnel; Receiving, in-process, & finished device acceptance
MSS 01DEC NWE-DO Device Cites by Section 1. Corrective & preventive action 2. Complaint files 3. Receiving, in-process, & finished device acceptance 4. Production & process controls 5. Medical Device Reporting
MSS 01DEC068 Summary 483s FDA – Wide NWE-DO CitesSections (a)22100(b) CAPA (100) 100(a)25(b)198(a) Quality Audit (22) Complaints (198) (a)22 Recv (80) 75(a)100(b)100(a) MDRs (803) P&PC (70) 100(b)/ 22 (2005) 100(a) 25(b), (a)(2),1 00(b)198(a )(3) Recv (80); Personnel (25) MDRs (803)
MSS 01DEC069 Actions 1 Seizure 1 Seizure Unapproved device Unapproved device Did not meet performance standard Did not meet performance standard Mislabeled Mislabeled Unregistered facility Unregistered facility
MSS 01DEC0610 Actions 3 Warning Letters 3 Warning Letters 1.Corporate – wide 2.Recidivist 3.QSR + MDR + Corrections & Removals
MSS 01DEC0611 Actions Imports Imports Detained Detained Examination gloves (GMPs, holes) Examination gloves (GMPs, holes) Bandages (GMPs) Bandages (GMPs) Xray equipment (no 510(k)) Xray equipment (no 510(k)) UV lamp (no accession #) UV lamp (no accession #) Refused Refused Examination gloves (holes) Examination gloves (holes)
Device Initiatives FY 2005 Karen A. Coleman FDA Device National Expert.
Top 10 Medical Device Citations Regina A. Barrell Food and Drug Administration Office of Regulatory Affairs Office of Enforcement and Import Operations.
PREPARATION FOR FDA INSPECTION NEMA/ADVAMED/PHILIPS September 25, 2003 Robert L. Turocy.
MWDG MWDG May 2007 Meeting CAPA Best Practices Open Discussion 1.
Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,
REGULATIONS for SUPPLIES, EQUIPMENT, REAGENTS and TESTING JILL HOAG BS, SBB(ASCP) CQA(ASQ) AABB STAFF LEAD ASSESSOR 1.
21 CFR PART 11 REGULATIONS RECOMMENDATIONS FOR CHANGES FDA PUBLIC MEETING ON PART 11 REGULATIONS – JUNE 11, 2004 NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION.
Hot Topics Kimberly A. Trautman FDA’s Medical Device Quality System Expert.
QSIT Management Controls QSIT Workshops. Management Controls u Importance u Assessment u Demonstration of Compliance.
INTRODUCTION Quality System in Medical Devices ©2014 Salt Lake Community College. All rights reserved.
Pre-Market and the QSR Presented by: Dawn Fernandes.
Lecture Topic 4: Good Manufacturing Practices (GMPs)
1 FDA Medical Device Enforcement and Quality System Update Kimberly Trautman FDAs Medical Device Quality Systems Expert Office of Compliance, CDRH.
21 CFR Part 11 course syllabus / Ilan Shaya 21CFR Pat 11 | Objective | Audience |Course Outline | Details 15-16/7/2013.
FIELD COMPLIANCE UPDATE CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
Checking & Corrective Action EPA Regions 9 & 10 and The Federal Network for Sustainability.
Good Manufacturing Practice (GMP) Compliance: GMPs EXPLAINED Presented by Raymond A. Bonner Nathan C. Sheers SIDLEY AUSTIN BROWN & WOOD, LLP Washington,
Radiopharmaceutical Production Quality Manual STOP.
New England District Update MassMEDIC Conference December 1, 2010 Waltham, MA.
Metric, Data and Analysis Biometrics Ricki A. Chase Director, Investigations Branch
QSR and GLP What exactly are these?. Key Terms QSR: Quality System Regulations –Standard produced by the FDA which companies MUST follow Include standards.
Building a Cradle-to-Grave Approach with Your Design Documentation and Data Denise D. Dion, EduQuest, Inc. and Gina To, Breathe Technologies, Inc.
The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.
Evolving IT Framework Standards (Compliance and IT)
Regulatory Auditing. Audit Areas Management Responsibility Auditing (internal and external) Design Control Document Control Purchasing Control Identification.
What FDA Looks for When Inspecting IRBs and Sponsors Marian J. Serge Nurse Consultant Division of Bioresearch Monitoring Office of Compliance Center for.
FDA QS reg/CLIA Comparison: Overview Open Meeting on the Oversight of LDTs November 22, 2010 Katherine Serrano Office of In Vitro Diagnostic Device Evaluation.
Biopharmaceutical Quality Cynthia H Sarnoski PhD 28 th June 2012.
QC/QA Mary Malarkey Director, Division of Case Management Office of Compliance and Biologics Quality Center for Biologics Evaluation and Research March.
1 Auditing for Compliance It is important to periodically do self-inspections to assure that your policies, practices, procedures, etc. meet the minimum.
Session 6: Data Integrity and Inspection of e-Clinical Computerized Systems May 15, 2011 | Beijing, China Kim Nitahara Principal Consultant and CEO META.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
Page - 1 Using the Cost of Poor Quality to Drive Process Improvement March, 2006 Presented by: Dan Olivier, Certified Software Solutions, Inc.
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
FDA Warning Letter CAPA September 2010 Dr. Guido Heinrichs.
Device regulations USA Dr Phil Warner. USA Regulations MEDICAL DEVICES Food, Drug & Cosmetics Act Medical Device Amendments of 1976 (and other things)
Inspection Issues in the Analytical Laboratory: An FDA Perspective Yvonne McKnight Chemist US Food and Drug AdministrationPhone: x
1 AUDITING A QUALITY IMPROVEMENT TOOL NOVEMBER 18,2015 Joel Schwartzman Retired
Module 2Slide 1 of 26 WHO - EDM Quality Management Basic Principles of GMP Part One.
FDA Medical Device Update US Food and Drug Administration New England District.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
HOW TO CREATE AN AUDIT READY PHILOSOPHY AND CULTURE By: Jake Walton Regulatory Auditor, Nelson Laboratories, Inc. 21 June 2011.
Medical Lab Accreditation in India - stepwise process QCI Bio-Rad Feb STEPS TO NABL Medical Laboratory Accreditation in India Dr Thuppil Venkatesh.
1 Investigational Device Exemption (IDE) Overview for IRBs Marian Serge, RN Division of Bioresearch Monitoring Office of Compliance Center for Devices.
Who is Responsible?. 2 Course Objectives Help you decide that safety IS everybody’s business and why Provide you with an understanding of accident.
Panel V Judicial Accountability & System Transparency SURVEY Commercial Enforcement and Insolvency Systems Legal Vice Presidency The World Bank.
Mrs. Ford. If the price of gas increases from $1.01 per gallon to $1.21 per gallon, what is the percent of increase? 1.21 – 1.01/ 1.01 =.198 or 20% What.
Compliance From The Ground Up September 18, 2013 Earlene Gibbons Director, Operational Technology.
© 2017 SlidePlayer.com Inc. All rights reserved.